Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Autopsy & Case Reports|January 10, 2022
Nodal Langerhans cell neoplasm: detailing the diagnostic quandariesZachariah Chowdhury, Juhi Varshney, Anil Singh, et al.
Ecancermedicalscience|November 26, 2021
Exceptional response to oral metronomic chemotherapy in a rare case of sinonasal mucosal melanomaAnukul Karn, Satvik Khaddar, Amit Agrawal, et al.
South Asian Journal of Cancer|January 2, 2023
Prognostic Impact of Baseline Liver Metastasis in ALK Fusion-Positive Metastatic Lung Cancer: A Retrospective ReviewSatvik Khaddar, Akhil Kapoor, Vanita Noronha, et al.
Ecancermedicalscience|June 28, 2023
Neoadjuvant chemotherapy in a rare type of very locally advanced sinonasal carcinomas - long-term results from a tertiary care centreSaswata Saha, Vijay M Patil, Vanita Noronha, et al.
South Asian Journal of Cancer|March 24, 2025
Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained SettingsAmit Kumar, Akhil Kapoor, Vanita Noronha, et al.
Cancer Medicine|February 16, 2021
A real-world data of Immune checkpoint inhibitors in solid tumors from IndiaVanita Noronha, George Abraham, Vijay Patil, et al.
Ecancermedicalscience|January 20, 2022
Diclofenac versus tramadol for mucositis related pain in head and neck cancer patients undergoing concurrent chemoradiation-a phase 3 studyAmit Joshi, Vijay Maruti Patil, Vanita Noronha, et al.
Eclinicalmedicine|May 31, 2019
Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung CancerVijay Patil, Vanita Noronha, Amit Joshi, et al.
The Lancet. Global Health|August 23, 2020
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trialVijay Patil, Vanita Noronha, Sachin Babanrao Dhumal, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2024
Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancerVanita Noronha, Vijay Patil, Pankaj Chaturvedi, et al.
Pageof 1